Untargeted Lipidomics Highlight the Depletion of Deoxyceramides during Therapy-Induced Senescence

Alec Millner1, Darleny Y Lizardo1, Gunes Ekin Atilla-Gokcumen1

  • 1Department of Chemistry, University at Buffalo, The State University of New York (SUNY), Buffalo, NY, 14260, USA.

Proteomics
|April 9, 2020
PubMed

Insights

Therapy-induced senescence involves cell cycle arrest and resistance to death. This study identifies depleted 1-deoxyceramides in senescent cells, suggesting they play a key role in this process.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Cancer Research

Background:

  • Therapy-induced senescence is a cell cycle arrest triggered by chemotherapy, leading to treatment resistance.
  • Senescent cells resist death, potentially hindering chemotherapeutic efficacy.
  • Lipids may influence cell survival and senescence, warranting investigation of the lipidome.

Purpose of the Study:

  • To investigate the role of lipids in therapy-induced senescence.
  • To identify specific lipid species altered during senescence.
  • To explore the functional significance of identified lipids in senescence.

Main Methods:

  • Established a tissue culture model for therapy-induced senescence.
  • Performed comparative analysis of cellular lipidomes in senescent versus proliferating cells.
  • Utilized mass spectrometry to identify and quantify lipid species.

Main Results:

  • Identified 17 lipid species with significant changes in senescent cells.
  • Found that 11 of these species were atypical sphingolipids, specifically 1-deoxyceramides/dihydroceramides.
  • Observed depletion of 1-deoxyceramides in senescent cells.

Conclusions:

  • 1-deoxyceramides are significantly depleted in therapy-induced senescent cells.
  • Supplementation with 1-deoxyceramides or their precursors reduces senescence.
  • These atypical sphingolipids play a crucial role in regulating senescence.